Cue Biopharma, Inc. (CUE) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 28.92M |
| Enterprise Value | 5.99M |
| P/E Ratio | -6.67 |
| PEG Ratio | -0.04 |
| Price/Sales Ratio | 2.95 |
| Price/Book Ratio | 8.18 |
| Enterprise/Revenue | 2.56 |
| Enterprise/EBITDA | -5.29 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.6 |
| Operating Margin | -0.6 |
AD
Management Effectiveness
| Return On Assets | -0.63 |
| Return On Equity | -0.98 |
Income Statement
| Revenue | 27.47M |
| Revenue/Share | 6.81 |
| Gross Profit | 27.47M |
| EBITDA | -22.27M |
| Net Income | -26.6M |
| Diluted EPS | -8.4 |
Balance Sheet
| Total Cash | 16.38M |
| Total Cash/Share | 3.41 |
| Total Debt | 3.44M |
| Total Debt/Equity | 0.16 |
| Current Ratio | 3.57 |
| Book Value Per Share | 4.49 |
Price History
| 52-Week Change | 57.79 |
| 52-Week High | 45.5 |
| 52-Week Low | 4.98 |
| Moving Average 50 Days | 27.3 |
| Moving Average 200 Days | 17.53 |
Statistics
| Average Volume | 583,158 |
| Shares Outstanding | 2.63M |
| % Held by Institutions | 19.81 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
| Last Split Date | April 24, 2026 |
AD
